<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04276389</url>
  </required_header>
  <id_info>
    <org_study_id>2018015</org_study_id>
    <nct_id>NCT04276389</nct_id>
  </id_info>
  <brief_title>OCT- Versus Angiography-guided Paclitaxel Drug-Coated Balloon Angioplasty in De Novo Coronary Artery</brief_title>
  <official_title>OCT- Versus Angiography-guided Paclitaxel Drug-Coated Balloon Angioplasty in De Novo Coronary Artery After Lesion Preparation With Scoring Balloon - A Prospective Multicenter Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Anzhen Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Anzhen Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      OCT allows precise evaluation of intimal injury after lesion preparation and may improve the
      acute results and long-term outcomes after paclitaxel drug-coated balloon angioplasty. This
      prospective multicenter cohort study aims to assess the efficacy and safety of OCT- versus
      angiography-guided paclitaxel drug-coated balloon angioplasty in middle-sized de novo
      coronary artery after lesion preparation with scoring balloon.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2017</start_date>
  <completion_date type="Anticipated">August 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Late lumen loss</measure>
    <time_frame>9 months</time_frame>
    <description>Evaluated by QCA</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of binary restenosis</measure>
    <time_frame>9 months</time_frame>
    <description>Evaluated by QCA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target lesion failure</measure>
    <time_frame>9 months</time_frame>
    <description>Including death, target vessel myocardial infarction, or target lesion revascularization</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>OCT-guided arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Angiography-guided arm</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>OCT-guided paclitaxel drug-coated balloon angioplasty</intervention_name>
    <description>OCT-guided paclitaxel drug-coated balloon angioplasty in middle-sized de novo coronary artery</description>
    <arm_group_label>OCT-guided arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Angiography-guided paclitaxel drug-coated balloon angioplasty</intervention_name>
    <description>Angiography-guided paclitaxel drug-coated balloon angioplasty in middle-sized de novo coronary artery</description>
    <arm_group_label>Angiography-guided arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. 18 to 85 years old

          2. Patients have ischemic symptoms or evidence of myocardial ischemia (inducible or
             spontaneous) in the presence of a stenosis of at least 50% in a native coronary
             artery, including stable angina, unstable angina, or silent ischemia.

          3. Reference vessel diameter &gt;2.5 mm, and &lt;4.0 mm.

          4. Lesion length of &lt;22 mm

          5. Written informed consent

        Exclusion Criteria:

          1. Myocardial infarction within 4 weeks, including ST-elevation myocardial infarction and
             non-ST-elevation myocardial infarction

          2. Cardiogenic shock (systolic arterial pressure &lt;90mmHg), congestive heart failure (NYHA
             or Killipâ‰¥3)

          3. Chronic kidney disease (eGFR &lt;30 ml/min)

          4. Lesion length &gt;22 mm, or vessel diameters of &lt;2.5 mm or &gt;4.0 mm

          5. Stents covering a major side branch (&gt;2 mm)

          6. Left main lesion

          7. Graft lesion

          8. Aortic-coronary ostial lesion

          9. In-stent restenotic lesion

         10. Chronic total occlusion

         11. Severe calcified lesions.

         12. Visible angiographic thrombus

         13. Severe comorbidities: eg. malignancy (life expectancy &lt;2 years)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Shao-Ping Nie, MD, PhD</last_name>
    <phone>86-10-84005256</phone>
    <email>spnie@ccmu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yaping Zeng, MD</last_name>
    <phone>86-10-84005255</phone>
    <email>zengyaping2@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Beijing Anzhen Hospital, Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <zip>100029</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yaping Zeng, MD</last_name>
      <phone>86-10-84005255</phone>
      <email>zengyaping2@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Xiao Wang, MD</last_name>
      <phone>86-10-84005255</phone>
      <email>spaceeye123@126.com</email>
    </contact_backup>
    <investigator>
      <last_name>Shao-Ping Nie, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 18, 2020</study_first_submitted>
  <study_first_submitted_qc>February 18, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 19, 2020</study_first_posted>
  <last_update_submitted>February 18, 2020</last_update_submitted>
  <last_update_submitted_qc>February 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Anzhen Hospital</investigator_affiliation>
    <investigator_full_name>Shao-Ping Nie</investigator_full_name>
    <investigator_title>Professor of Medicine, Director, Emergency &amp; Critical Care Center</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paclitaxel</mesh_term>
    <mesh_term>Albumin-Bound Paclitaxel</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

